Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Hamilton

Showing results (121-130 of 186) with videos related to

Pageof 19
Sort By:
Japanese Journal of Cancer Research : Gann|September 1, 1986
Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycinT Tsuruo, T C Hamilton, K G Louie, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesisA K Godwin, A Meister, P J O'Dwyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Drug resistance, supportive care and dose intensityE G de Vries, T C Hamilton, M Lind, et al.
Cancer Research|August 15, 1993
Transformation of rat ovarian epithelial and Rat-1 fibroblast cell lines by RAST24 does not influence cisplatin sensitivityR P Perez, K Hamaguchi, P A Tracey, et al.
Cancer Research|May 1, 1996
Identification of two candidate tumor suppressor genes on chromosome 17p13.3D C Schultz, L Vanderveer, D B Berman, et al.
International Journal of Cancer|December 20, 1996
Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancerH G Dyck, T C Hamilton, A K Godwin, et al.
Cancer Research|July 29, 1998
AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cellsA X Liu, J R Testa, T C Hamilton, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1996
Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the ratK B Mackay, S J Bailey, P D King, et al.
Cancer Research|September 1, 1986
Adoptive cellular immunotherapy of human ovarian carcinoma xenografts in nude miceJ R Ortaldo, H R Porter, P Miller, et al.
Cancer Research|November 1, 1984
Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletionJ A Green, D T Vistica, R C Young, et al.
Pageof 19

Showing results (121-130 of 186) with videos related to

Sort By:
Pageof 19
Japanese Journal of Cancer Research : Gann|September 1, 1986
Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycinT Tsuruo, T C Hamilton, K G Louie, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesisA K Godwin, A Meister, P J O'Dwyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Drug resistance, supportive care and dose intensityE G de Vries, T C Hamilton, M Lind, et al.
Cancer Research|August 15, 1993
Transformation of rat ovarian epithelial and Rat-1 fibroblast cell lines by RAST24 does not influence cisplatin sensitivityR P Perez, K Hamaguchi, P A Tracey, et al.
Cancer Research|May 1, 1996
Identification of two candidate tumor suppressor genes on chromosome 17p13.3D C Schultz, L Vanderveer, D B Berman, et al.
International Journal of Cancer|December 20, 1996
Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancerH G Dyck, T C Hamilton, A K Godwin, et al.
Cancer Research|July 29, 1998
AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cellsA X Liu, J R Testa, T C Hamilton, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1996
Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the ratK B Mackay, S J Bailey, P D King, et al.
Cancer Research|September 1, 1986
Adoptive cellular immunotherapy of human ovarian carcinoma xenografts in nude miceJ R Ortaldo, H R Porter, P Miller, et al.
Cancer Research|November 1, 1984
Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletionJ A Green, D T Vistica, R C Young, et al.
Pageof 19